Abstract: A process for producing N-(bicyclo[2.2.1]hept-5-en-2-ylmethyl)-1,1,1-trifluoromethanesulfonamide represented by formula [3]. The process includes the step of reacting trifluoromethanesulfonic anhydride with 1-bicyclo[2.2.1]hept-5-en-2-ylmethanamine in the presence of water and in the presence of a base selected from the group consisting of alkali metal hydroxides, alkaline-earth metal hydroxides and basic salts containing an alkali metal or an alkaline-earth metal.
Abstract: A medicament for enhancing an effect of a cancer therapy based on a mode of action of DNA injury, which comprises as an active ingredient a compound represented by the general formula (I) or a physiologically acceptable salt thereof: wherein R represents an aryl-substituted alkyl group, an heteroaryl-substituted alkyl group, a cycloalkyl-substituted alkyl group, or a cyclic hydrocarbon group wherein said cyclic hydrocarbon group may be saturated, partly saturated, or aromatic; or Z may bind to R to form a cyclic structure, Z represents a hydrogen atom or a C1 to C6 alkyl group. The medicament enhanced the effect of the cancer therapy and decreases a dose of an anticancer agent and/or radiation, and therefore, can reduce side effects resulting from the cancer therapy.
Type:
Grant
Filed:
June 7, 2002
Date of Patent:
June 16, 2009
Assignee:
Institute of Medicinal Molecular Design, Inc.
Abstract: A method of dehydrogenating an amine-borane having the formula R1H2N—BH2R2 using base metal catalyst. The method generates hydrogen and produces at least one of a [R1HN—BHR2]m oligomer and a [R1N—BR2]n oligomer. The method of dehydrogenating amine-boranes may be used to generate H2 for portable power sources, such as, but not limited to, fuel cells.
Type:
Grant
Filed:
October 30, 2006
Date of Patent:
June 9, 2009
Assignee:
Los Alamos National Security, LLC
Inventors:
Johanna Marie Blacquiere, Richard Jeffrey Keaton, Ralph Thomas Baker
Abstract: The invention relates to a process for preparing modafinil having a defined granulometry which comprises the steps of: a) preparing a solution of DMSAM; b) contacting the solution obtained with NH3 at a predetermined temperature and a predetermined stirring; and c) isolating the modafinil formed, wherein said temperature and said stirring are predetermined in order to obtain said defined granulometry.
Abstract: An aqueous process is described in which thiocarboxylate silane is produced from haloalkyl silane by reaction of the haloalkyl silane with an aqueous solution of thiocarboxylate salt in the presence of a catalytically effective amount of alkylguanidinium salt.
Type:
Grant
Filed:
April 14, 2005
Date of Patent:
May 5, 2009
Assignee:
Momentive Performance Materials Inc.
Inventors:
Tiberiu Ladislau Simandan, Thomas Link Guggenheim
Abstract: The present invention is a method of preparing affinity ligands, which method comprises to provide a cyclic scaffold comprising a thiol group, a carbonyl group and an amine group; to derivatize the amine group of said scaffold with an electrophile that carries either a functionality capable of affinity interaction or a functionality capable of a second interaction with a target molecule; and to open up the derivatized scaffold and add an amine that carries either a functionality capable of a second interaction or a functionality capable of affinity interaction with a target molecule. The method provides provide affinity ligands, which are capable of affinity interaction as well as a second kind of interaction.
Abstract: In a process and an apparatus for synthesizing urea which synthesize urea from ammonia and carbon dioxide, the operating condition can be grasped easily and with good accuracy. A process for synthesizing urea which includes: a reaction step of obtaining a urea synthesis solution which contains urea, unreacted ammonia, unreacted carbon dioxide and water by causing ammonia and carbon dioxide to react with each other; a stripping step of separating a gas mixture containing the unreacted ammonia and the unreacted carbon dioxide by stripping the urea synthesis solution by using at least a portion of raw material carbon dioxide; a condensing step of obtaining a condensed liquid by condensing the gas mixture in an absorbing medium while cooling the gas mixture; a recycling step of recycling the condensed liquid to the reaction step; and a step of measuring the density of the condensed liquid online. An apparatus for carrying out this process is provided.
Abstract: A stilbene derivative compound having a specific substituent at the specific position thereof to exert good compatibility with a binder resin and to tend to be uniformly dispersed in a photoconductive layer so as to allow prolonged specified sensitive property, a process for the production thereof, and an electrophotographic photoconductor containing the stilbene derivative compound are provided. For preparing a stilbene derivative compound represented by the general formula (1), a specified formylated triphenylamine derivative compound and a specified diphosphate ester derivative compound are allowed to be reacted with each other in the presence of a catalyst.
Abstract: A process for preparing a synthetic petroleum sulfonate comprising (a) reacting at least one aromatic compound with a mixture of olefins selected from olefins having from about 8 to about 100 carbon atoms, in the presence of an acidic ionic liquid catalyst, wherein the resulting product comprises at least about 50 weight percent of a 1,2,4 tri-substituted aromatic compound or a 1,2,3 tri-substituted aromatic compound or mixtures thereof; (b) reacting the product of (a) with sulfur trioxide, which has been diluted with air; and (c) neutralizing the product of (b) with an alkali or alkaline earth metal hydroxide.
Type:
Grant
Filed:
December 21, 2005
Date of Patent:
November 11, 2008
Assignee:
Chevron Oronite Company LLC
Inventors:
Curt B. Campbell, Thomas V. Harris, Gilles Sinquin
Abstract: The present invention relates to a process for preparing severely sterically hindered secondary amine ether alcohols and diamine polyalkenyl ethers by reacting a primary amino compound with a polyalkenylether glycol in the presence of a high activity nickel powder hydrogenation catalyst which is marked by high conversion of reactants and increased selectivity to desired final product.
Type:
Grant
Filed:
February 1, 2005
Date of Patent:
October 28, 2008
Assignee:
ExxonMobil Research and Engineering Company
Inventors:
Christine Nicole Elia, Michael Siskin, Michael Charles Kerby, Adeana Richelle Bishop, Edmund John Mozeleski, Andrzej Malek
Abstract: The present invention relates to intermediates of the formula useful in the preparation of piperazinyl-substituted indan derivatives, wherein Y is CONR2 wherein R2 is H or C1-C6 alkyl; R3 is C1-C6 alkyl, C3-C6 cycloalkyl or (CH2)n-aryl, wherein aryl is phenyl or a heteroaromatic ring containing one or two heteroatoms selected from N, O and S and which may be mono- or di-substituted with R4 and/or R5, wherein R4 and R5 are as defined in the specification; and R9 is H, C1-C6 alkyl, C3-C6 cycloalkyl, OCF3, OCHF2, OCH2F, halogen, CN, CF3, OH, C1-C6 alkoxy, C1-C6 alkoxy-C1-C6 alkyl, NR6R7, SO3CH3, SO3CF3, SO2NR6R7, an unsubstituted or substituted heterocyclic or heteroaromatic ring containing one or two heteroatoms selected from N and O, wherein the substituent(s) is(are) C1-C6 alkyl; or COR8; wherein R6, R7 and R8 are as defined in the specification. The invention further relates to a process for the preparation of the intermediates.
Type:
Grant
Filed:
October 3, 2006
Date of Patent:
October 21, 2008
Assignee:
AstraZeneca AB
Inventors:
Stefan Berg, Lennart Florvall, Svante Ross, Seth-Olov Thorberg
Abstract: Severely sterically hindered secondary aminoether alcohols are prepared by reacting an organic carboxylic acid or alkali metal salt of an organic carboxylic acid with a sulfonyl halide, a sulfuryl halide, a mixed sulfuryl ester halide or a mixed sulfuryl amide halide to yield a sulfonic-carboxylic anhydride compound which is then reacted with a dioxane to cleave the ring of the dioxane, yielding a cleavage product which cleavage product is then aminated with an alkylamine and hydrolyzed with base to yield the severely sterically hindered secondary aminoether alcohol.
Type:
Grant
Filed:
February 1, 2005
Date of Patent:
September 30, 2008
Assignee:
Exxonmobil Research and Engineering Company
Inventors:
Michael Siskin, Alan Roy Katritzky, Kostyantyn Mykolayevich Kirichenko
Abstract: A novel class of compounds that includes HPTS-Cys-MA, and methods of making them are disclosed herein. The class of compounds including HPTS-Cys-MA are useful as fluorescent dyes for analyte detection.
Abstract: Non-C2-symmetric bisphospholane ligands and methods for their preparation are described. Use of metal/non-C2-symmetric bisphospholane complexes to catalyze asymmetric transformation reactions to provide high enantiomeric excesses of formed compounds is also described.
Type:
Grant
Filed:
January 20, 2005
Date of Patent:
August 19, 2008
Assignee:
Warner Lambert Co.
Inventors:
Garrett Stewart Hoge, II, Om Prakash Goel
Abstract: In an integrated process for urea and melamine production, urea is produced in a urea plant (12) comprising a high pressure urea synthesis section (15) and a urea recovery section (16) for separating urea from a carbamate aqueous solution, and melamine is produced in a melamine plant (11) wherein off-gases resulting as byproducts of the melamine synthesis are discharged therefrom at a pressure of at least 2 bar and recycled to the high pressure urea synthesis section (15).
Abstract: The present invention provides a novel process for preparation of bisphosphonic acids or salts thereof, e.g. alendronic acid, by reacting a carboxylic acid, phosphorous acid and a halophosphorous compound in a water miscible neutral solvent.
Abstract: Certain lipophilic polycationic sulfonamides are provided and are useful for treating various diseases or conditions and particularly sepsis.
Type:
Grant
Filed:
June 7, 2006
Date of Patent:
August 12, 2008
Assignees:
The University of Kansas, Mediquest Therapeutics, Inc.
Inventors:
Mark R. Burns, Sunil A. David, Scott A. Jenkins
Abstract: The present invention relates to novel polymorphs of tolterodine tartrate, to processes for their preparation and to pharmaceutical compositions containing them.
Abstract: A compound of the formula: wherein Ar is an aromatic ring assembly group which may be substituted or a fused aromatic group which may be substituted; X is (i) a bond, (ii) —S—, —SO— or —SO2—, (iii) C1-6 alkylene, C2-6 alkenylene or C2-6 alkynylene, etc.
Type:
Grant
Filed:
August 21, 2003
Date of Patent:
August 14, 2007
Assignee:
Takeda Pharmaceutical Company Limited
Inventors:
Kaneyoshi Kato, Jun Terauchi, Hiroaki Fukumoto, Mitsuru Kakihana
Abstract: The present invention relates to compounds of formula I wherein R1, R2 and R3 are defined herein, their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above compounds, medicaments containing them and their manufacture, as well as the use of the above compounds in the control or prevention of illnesses such as cancer.
Type:
Grant
Filed:
June 29, 2006
Date of Patent:
April 24, 2007
Assignee:
Hoffmann-La Roche Inc.
Inventors:
Edward Boyd, Frederick Brookfield, Jonathan Gridley, Manfred Kubbies, Raymond Lau, Ulrike Reiff, Georg Tiefenthaler, Wolfgang von der Saal, Thomas von Hirschheydt, Timothy Woodcock